Pakistan Epidemiological Survey in Acute Pharyngitis
1 other identifier
observational
5,140
1 country
1
Brief Summary
GABHS are common etiological agents for acute pharyngitis. However, local data is limited and large scale surveillance studies have not been done. This study aims to evaluate the disease burden in the community due to GABHS. In this study, patients presenting with signs of acute pharyngitis will be evaluated. Patients with fulfilling the inclusion criteria will be tested for Rapid Antigen Detection test (RADT)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2012
CompletedStudy Start
First participant enrolled
November 1, 2012
CompletedFirst Posted
Study publicly available on registry
November 2, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedSeptember 15, 2014
September 1, 2014
1 year
November 1, 2012
September 12, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the prevalence of GABHS in patients with acute pharyngitis.
12 months
Secondary Outcomes (2)
To study the prevalence of GABHS in acute pharyngitis across different age groups.
12 months
To study the correlation of centor score and RADT results.
12 months
Study Arms (1)
Acute Pharyngitis
Subjects presenting with acute pharyngitis
Eligibility Criteria
The study population will include children and adults presenting with sore throat, temperature greater than 100.40 F, tonsillar exudates and cervical adenopathy will be included.
You may qualify if:
- Male and female subjects with signs of acute pharyngitis (duration of symptoms \< 14 days)
- Subjects with sore throat
- Fever with sudden onset (temperature \> 100 0 F (380 C)
- Exposure to Streptococcus within the preceding 2 weeks
- Children 3 years of age and above
- Subjects / guardians giving written authorization to participate in the study
You may not qualify if:
- Recurrent or persistent cases of sore throat
- Complicated pharyngitis (peritonsillar abscesses, Lemierre disease, Vincent's angina)
- Severe comorbidity
- Immunosuppression or history of acute rheumatic fever
- Special circumstances, such as sore throat after travel in past 2 weeks, sore throat linked to sexual transmission or rare epidemics (e.g. diphtheria)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Suresh Kumarlead
- Isra Universitycollaborator
Study Sites (1)
ISRA University
Hyderābād, Sindh, Pakistan
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
November 1, 2012
First Posted
November 2, 2012
Study Start
November 1, 2012
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
September 15, 2014
Record last verified: 2014-09